P
Paulo Gustavo Kotze
Researcher
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Jul 15, 2026
Special Aspects of IBD management in South America, Early Surgery in Crohn's disease and the emerging role of robotic surgery in IBD surgery
2:52
3:11
3:25
12:22

Axel DignaßHOST
But this is probably something which is very interesting and I think it really got attention when the LYRIQ trial came out and now we are at the 10-year level of the lyric trial so perhaps you can explain a little bit the background and your opinion on this as a surgeon

Paulo KotzeGUEST
It took long to recruit because, of course, randomization between surgery and medical therapy is not something we see every day.

Paulo KotzeGUEST
And I think that if they did the protocol today, they would do patient preference trial because it makes more sense.
9 MINS LATER

Axel DignaßHOST
For me as a gastroenterologist doing an appendectomy on a very healthy patient, must be somehow a high risk patient, seems still a little bit strange and The background, at least the immunological background, is probably there, but I would like to learn about your opinion on this very exciting area of research.